Woebot Health Secures $9.5 Million Investment From Leaps by Bayer

Strategic funding marks Leaps by Bayer’s first in mental health and aims to help improve the treatment of prevalent mental health conditions globally

Woebot Health today announced that Leaps by Bayer, the impact investment arm of Bayer AG, has made a $9.5 million strategic investment in the company to help accelerate further development of its AI-powered behavioral health platform and products. The stake in Woebot Health marks Leaps by Bayer’s first investment in mental health, broadening a portfolio defined by a commitment to address the global need for pioneering solutions that deliver engaging and continuous care. The announcement follows Woebot Health’s $90 million Series B round in 2021 and brings total investment in the company to date to $123.5 million.

Download Our Top Whitepaper : Building Reliable and Secure Fintech Systems in 2022

“Leaps by Bayer is committed to advancing technologies that solve some of humanity’s biggest problems in health and agriculture”

“Leaps by Bayer is committed to advancing technologies that solve some of humanity’s biggest problems in health and agriculture,” said Head of Leaps by Bayer Dr. Jürgen Eckhardt. “Woebot Health’s mission and products are well aligned with our leaps number 5 and 10 — to protect the brain and the mind and to transform health with data. With its deep focus on clinical evidence and unique AI-based platform and products, Woebot Health is forging a new frontier in behavioral health at a critical time in our world. We’re excited to support endeavors that will make tech-supported continuous care a reality for all.”

Eckhardt added that the investment coincides with a collaboration between Woebot Health and Bayer Pharmaceuticals initiated as part of the G4A Digital Health Partnerships Program, for which the companies signed a Letter of Intent together with Bayer Integrated Care to assess joint opportunities on delivering integrated care solutions in mental health that ultimately improve people’s lives.

“We’re honored to join forces with a company that is committed to innovative, evidence-based approaches to conquering such significant challenges,” said Michael Evers, CEO of Woebot Health. “Great mental health outcomes depend on supportive relationships. Together with our employer, health system and plan partners, we can create a world where empathic and meaningfully engaging mental health interventions reach everyone in their moment of need.”

Recommended AI News: Datometry Hyper-Q Now Available in the Microsoft Azure Marketplace

[To share your insights with us, please write to sghosh@martechseries.com]